Common IND Gaps That Trigger Clinical Holds
January 14, 2026
Introduction Filing an Investigational New Drug (IND) application is a pivotal milestone in drug development. Yet we frequently see clinical holds imposed not due to
preclinical data
How to Build a Robust IND Package: Essential Elements for FDA Approval
July 18, 2025
Creating a strong IND (Investigational New Drug) package is critical for gaining FDA approval to initiate clinical trials. A well-prepared IND submission demonstrates that your